NOVOREX IBERICA, founded in 2020, operates in the pharmaceutical industry. The company recently secured a significant KRW11.50B Series A investment on 24 November 2023, attracting a consortium of notable investors including Company K Partners, KB Investments, UTC 2019 BioVentureFund, Woori Venture Partners, BNH Investment, Hana Ventures, AON Investment, Quad Asset Management, and Korea Technology Finance Corporation.
NOVOREX IBERICA
Founded 2020
3 employees
Series A
Total: $11.50B
Pharmaceutical
General Information
Company Name
NOVOREX IBERICA
Founded Year
2020
Employees
3
Industries
Pharmaceutical
Funding Stage
Series A
BounceWatch is an independent company data service, not affiliated with NOVOREX IBERICA. To contact NOVOREX IBERICA, visit novorex.com.
Is this your company?
Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.
Get Verified
Discover More
Pharmaceutical
About NOVOREX IBERICA
Funding Rounds & Investors (3)
View All| Funding Stage | Amount | Investors | Lead Investors | Date |
|---|---|---|---|---|
| Series A | KRW11.50B | 9 |
|
24 Nov 2023 |
| Seed Round | Undisclosed | 1 |
|
01 Jan 2023 |
| Non Equity Assistance | Undisclosed | - |
|
01 Mar 2020 |
FAQ About NOVOREX IBERICA
NOVOREX IBERICA was founded in 2020.
NOVOREX IBERICA operates in Pharmaceutical.
NOVOREX IBERICA has approximately 3 employees.
NOVOREX IBERICA has completed 3 funding rounds, raising a total of $11.50B. The latest funding stage is Series A.
We're actively collecting intelligence on NOVOREX IBERICA.
Source: BounceWatch company record for NOVOREX IBERICA, https://bouncewatch.com/company/novorex-iberica, updated 19 November 2024. When citing, please name BounceWatch and link this page.
